A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Halog Indications, Dosage, Storage, Stability - Halcinonide
Halog Indications, Dosage, Storage, Stability - Halcinonide
INDICATIONS
Halog Ointment (Halcinonide Ointment) 0.1 % is indicated for the relief
of the inflammatory and pruritic manifestations of corticosteroid-responsive
dermatoses.
DOSAGE AND ADMINISTRATION
Apply a thin film of 0.1 % Halog Ointment (Halcinonide Ointment) to the
affected area two to three times daily.
Occlusive Dressing Technique
Occlusive dressings may be used for the management of psoriasis or other
recalcitrant conditions. Apply a thin film of ointment to the lesion,
cover with a pliable nonporous film, and seal the edges. If needed additional
moisture may be provided by covering the lesion with a dampened clean
cotton cloth before the nonporous film is applied or by briefly wetting
the affected area with water immediately prior to applying the medication.
The frequency of changing dressings is best determined on an individual
basis. It may be convenient to apply Halog ointment under an occlusive
dressing in the evening and to remove the dressing in the morning (i.e.,
12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional
ointment should be applied without occlusion, during the day. Reapplication
is essential at each dressing change.
If an infection develops, the use of occlusive dressings should be discontinued
and appropriate antimicrobial therapy instituted.
HOW SUPPLIED
Halog Ointment (Halcinonide Ointment USP) 0.1%:
Tubes containing:
15 g (NDC 0003-0248-15)
30 g (NDC 0003-0248-20)
60 g (NDC 0003-0248-30)
Jars containing:
240 g (NDC 0003-0248-40) of ointment.
Storage
Store at room temperature; avoid excessive heat (104° F).
top
